SG Americas Securities’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.74M | Sell |
|
|||||
|
2025
Q2 | $2.11M | Buy |
|
|||||
|
2025
Q1 | $326K | Buy |
|
|||||
|
2024
Q4 | $311K | Sell |
|
|||||
|
2024
Q3 | $1.21M | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $69K | Sell |
|
|||||
|
2023
Q4 | $397K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $147K | Sell |
|
|||||
|
2022
Q3 | $270K | Sell |
|
|||||
|
2022
Q2 | $881K | Sell |
|
|||||
|
2022
Q1 | $3.85M | Sell |
|
|||||
|
2021
Q4 | $3.69M | Sell |
|
|||||
|
2021
Q3 | $4.8M | Buy |
|
|||||
|
2021
Q2 | $162K | Sell |
|
|||||
|
2021
Q1 | $697K | Buy |
|
|||||
|
2020
Q4 | $433K | Sell |
|
|||||
|
2020
Q3 | $725K | Sell |
|
|||||
|
2020
Q2 | $4.46M | Buy |
|
|||||
|
2020
Q1 | $125K | Buy |
|
|||||
|
2019
Q4 | $70K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $169K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $141K | Buy |
|
|||||
|
2017
Q2 | $76K | Buy |
|
|||||
|
2017
Q1 | $102K | Sell |
|
|||||
|
2016
Q4 | $183K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $57K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $120K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $225K | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $132K | Buy |
|
|||||
|
2014
Q1 | $108K | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $34K | Buy |
|